https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-des-inhibiteurs-de-la-pompe-a-protons/ 2024-07-08T14:37:57+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/consequences-du-passage-a-la-nouvelle-formule-du-levothyrox-en-france/ 2020-05-15T18:26:59+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/exposition-prolongee-a-des-fortes-doses-dacetate-de-cyproterone-et-risque-de-meningiome-chez-la-femme/ 2024-07-08T14:34:58+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/suivi-de-lutilisation-de-truvada-ou-generiques-pour-une-prophylaxie-pre%e2%80%90exposition-prep-au-vih/ 2020-05-15T18:26:21+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-du-mycophenolate/ 2020-05-15T18:25:14+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/usage-des-medicaments-de-ville-en-france-durant-lepidemie-de-covid-19-point-de-situation-a-la-fin-mars-2020/ 2020-09-30T08:39:48+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/usage-des-medicaments-de-ville-en-france-durant-lepidemie-de-covid-19-point-de-situation-apres-5-semaines-de-confinement-jusquau-19-avril-2020/ 2020-09-30T08:40:24+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/antiepileptiques-pendant-la-grossesse-et-risques-neurodeveloppementaux/ 2020-06-10T11:39:46+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid-19-usage-des-medicaments-de-ville-en-france-3/ 2020-10-08T08:49:53+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/hydroxychloroquine-ou-chloroquine-et-risque-dhospitalisation-pour-covid-19/ 2021-10-21T15:19:44+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid-19-antipaludeens/ 2020-10-08T08:49:33+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/scientific-reports/ 2020-10-15T11:18:40+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/chimotherapie-cancer-sein/ 2020-09-16T11:24:38+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/grossesse-et-maladie-inflammatoire-de-lintestin/ 2020-10-09T08:36:20+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/essure/ 2020-10-23T06:15:51+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid-19-usage-des-medicaments-de-ville-en-france-rapport4/ 2020-12-16T10:19:20+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/antiepileptiques/ 2020-10-23T06:14:58+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/prep-vih-2020/ 2021-01-11T12:15:44+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid-19-usage-des-medicaments-rapport5/ 2021-03-08T14:19:11+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-des-anti-vegf-pendant-lepidemie-de-covid-19/ 2020-12-18T07:52:53+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/coloscopies-covid-19/ 2021-01-07T14:29:45+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/anti-hypertenseurs-et-risque-de-covid-19/ 2021-03-08T14:18:10+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/surveillance-pharmaco-epidemiologique-des-vaccins-contre-la-covid-19/ 2021-03-08T14:18:45+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/medicaments-symptomes-gastrointestinaux-grossesse/ 2021-03-08T14:17:31+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/hautes-doses-acetate-cyproterone-meningiome-femme/ 2021-03-08T14:16:54+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/surveillance-pharmacoepidemiologique-vaccins-covid19-2/ 2021-03-08T14:16:33+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-de-la-contraception-et-des-inducteurs-de-lovulation-pendant-lepidemie-de-covid-19/ 2021-04-20T14:31:34+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid-19-facteurs-risques/ 2024-07-09T09:03:55+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/stents-ballons-aomi/ 2021-05-04T15:07:27+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/https-www-epi-phare-fr-app-uploads-2021-04-epi-phare_rapport_acetate_nomegestrol_et_meningiome_20210420-pdf/ 2024-07-09T09:04:34+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/rapport-chlormadinone-meningiome/ 2024-11-06T14:58:19+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/initiation-psoriasis-covid-19/ 2021-06-08T06:54:04+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/impact_vaccination_covid/ 2024-07-08T14:28:14+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid-19-usage-des-medicaments-rapport-6/ 2021-07-16T07:06:22+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccinations-obligatoires-en-france-en-2020-pendant-la-pandemie-de-covid-19/ 2021-07-16T07:05:43+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/prescriptions-pediatriques-ambulatoires-en-france-entre-2010-et-2019/ 2021-07-16T07:05:25+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid-19-medicaments-mici/ 2021-07-16T07:05:09+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-intravitreenne-anti-vegf/ 2021-07-16T07:04:51+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/medicaments-des-mici-et-issues-de-grossesse/ 2021-07-16T07:04:39+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/facteurs-de-risques-dhospitalisation-et-de-deces-a-lhopital-pour-covid-19/ 2021-09-07T06:39:45+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccin-pfizer-biontech-evenements-cardiovasculaires/ 2024-07-08T12:59:50+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/inhibiteurs-de-linterleukine-17-risque-de-mici-chez-les-patients-atteints-de-psoriasis-de-rhumatisme-psoriasique-et-de-spondylarthrite-ankylosante/ 2021-07-23T10:07:18+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/biologiques-infection-psoriasis/ 2021-09-07T06:40:43+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid-19-facteurs-risques-2/ 2022-01-05T14:04:43+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/infections-graves-chez-les-enfants-nes-de-meres-atteintes-de-mici-avec-exposition-in-utero-aux-thiopurines-et-aux-anti-tnf/ 2021-07-26T08:51:07+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/exposition-aux-traitements-lies-au-psoriasis-et-hospitalisation-ou-mortalite-hospitaliere-due-au-covid-19-pendant-la-premiere-et-la-deuxieme-vague-de-la-pandemie/ 2021-10-21T14:24:14+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/avk-syndrome-myelodysplasique/ 2021-09-30T07:04:37+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid19-chirurgie-dmi/ 2024-07-08T14:25:49+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/impact-vaccination-covid-octobre-2021/ 2024-07-08T13:55:05+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/myocardite-pericardite-vaccination-covid19/ 2024-07-09T09:05:11+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/mpi-personnes-agees/ 2022-01-05T13:52:35+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/jama-vaccins-covid19-cardiovasculaire-75ans/ 2021-12-23T09:30:46+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/prep-vih-2021/ 2024-07-08T14:31:23+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/article-vaccine-covid-vaccins-75ans/ 2022-01-31T07:47:50+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/ipp-cebp2021/ 2022-01-31T07:48:18+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid19-contraception2021/ 2022-01-31T07:48:52+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccins-covid-evenements-cv-18-74ans/ 2024-07-09T09:03:18+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/antivegf-infarctus-avc-deces-2022/ 2022-02-17T16:33:44+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/une-methode-sccs-modifiee-avec-application-a-la-securite-du-vaccin-covid-19/ 2022-02-17T16:33:23+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/impact-vaccination-sur-risque-formes-graves-covid-19-dans-les-dom/ 2024-07-09T09:01:58+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/risques-covid-vaccination/ 2024-07-09T09:01:11+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/taux-de-vaccination-pour-la-covid-19-des-femmes-enceintes-en-france/ 2022-02-17T16:23:31+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/efficacite-vaccins-janssen-pfizer-hospitalisation-covid19/ 2022-04-07T07:18:59+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/evolution-de-la-couverture-vaccinale-contre-la-covid-19-parmi-les-femmes-enceintes-en-france/ 2022-04-26T07:13:47+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/myocardite-pericardite-vaccination-covid19-12-50ans/ 2022-06-20T08:18:11+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/prescriptions-pediatriques-ambulatoires/ 2022-06-20T08:18:25+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/interventions-chirurgicales-covid19/ 2022-06-20T08:18:37+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/persistance-a-long-terme-des-medicaments-biologiques-pour-les-patients-atteints-de-psoriasis-et-de-rhumatisme-psoriasique/ 2022-06-20T08:18:49+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/meningiome-intracranien-progestatifs-puissants/ 2022-06-20T08:19:04+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/efficacite-vie-reelle-prep-vih/ 2022-06-20T08:19:23+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/statines-hospitalisation-covid19/ 2022-06-20T08:19:34+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/aspirine-covid19/ 2022-10-20T06:32:09+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccins-covid-19/ 2022-08-30T08:02:57+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/myocardite-pericardite-vaccination-covid19-naturecommunications/ 2022-08-30T08:03:44+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/risques-covid19-vaccination-lancet/ 2022-08-30T08:04:17+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/rappel-vaccination-covid-19/ 2022-08-30T08:04:48+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/myocardite-rappel-vaccin-covid19/ 2024-09-05T07:48:50+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/deploiement-utilisation-prep/ 2022-09-27T11:18:37+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/codeine-enfants-europe/ 2022-09-27T11:18:16+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-diu-siu-france/ 2022-09-27T11:17:50+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccins-covid19-outre-mer/ 2022-10-18T13:57:12+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-paxlovid/ 2022-10-20T06:24:47+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/exposition-maternelle-antitnf-thiopurines-tumeur-enfant/ 2022-09-14T11:24:53+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/polyarthrite-rhumatoide/ 2022-09-19T08:28:08+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/anti-tnf-grossesse-mici/ 2022-10-20T06:23:10+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/inhibiteurs-de-jak-et-risque-devenements-cardiovasculaires-indesirables-majeurs-et-devenements-thromboemboliques-veineux/ 2022-11-15T14:03:44+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/oxygenotherapie-2021/ 2022-11-15T14:04:02+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-biosimilaires-antitnf-scientificreports/ 2022-11-30T10:00:31+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-biosimilaires-antitnf-rapport/ 2024-07-09T09:02:37+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-vaccins_mono-bivalents/ 2023-01-06T14:29:50+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-paxlovid-novembre2022/ 2023-01-06T14:29:33+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/suivi-utilisation-prep-vih-2022/ 2023-01-06T14:29:14+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/acetate-de-cyproterone-evaluation-de-limpact-des-mesures-de-reduction-du-risque-de-meningiomes-intracraniens/ 2023-01-06T14:28:56+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/medicaments-inappropries-personnes-agees/ 2023-01-06T14:28:39+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-anti-infectieux/ 2023-01-06T14:28:14+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/valsartan-ndma/ 2023-01-06T14:25:17+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/association-entre-dispositifs-intra-uterins-au-levonorgestrel-et-lusage-ulterieur-de-psychotropes-en-france/ 2023-02-21T06:53:13+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/efficacite-rappels-omicron/ 2023-03-29T07:39:05+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/rituximab-hypersensibilite/ 2023-03-29T07:38:45+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/nejm-vaccins-bivalents/ 2023-05-24T12:09:18+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/finasteride-suicide/ 2023-04-03T08:30:35+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/prep-hsh/ 2023-06-26T14:36:26+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/sarscov2-cancer/ 2023-06-26T14:35:43+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/progestatifs-meningiomes-intracraniens/ 2024-07-09T09:00:16+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/ipp-infections-graves-enfant/ 2023-09-13T12:35:10+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/medicaments-biologiques-seconde-intention-psoriasis/ 2023-09-13T12:35:27+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/antibiotiques-grossesse/ 2023-09-13T12:35:45+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccination-covid19-omicron/ 2023-10-04T07:24:48+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/rapport_guillain-barre/ 2024-08-22T08:17:38+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/neurology_covid19_guillain-barre/ 2023-10-04T07:38:11+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/hospitalisations-covid%e2%80%9119-transplantation/ 2023-11-09T10:36:05+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/prep-vih-2023/ 2023-11-28T13:39:33+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/ipp-saignements/ 2024-01-12T07:19:43+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vedolizumab-ustekinimab/ 2024-02-09T08:17:54+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/grossesse-polyarthrite-rhumatoide/ 2024-02-09T08:17:31+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccins-covid%e2%80%9119-saignements-menstruels/ 2024-09-02T09:53:59+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/sep-grossesse/ 2024-02-09T08:16:42+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vasectomie/ 2025-06-19T11:28:56+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/persistance-securite-biosimilaire/ 2024-03-19T07:36:59+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/wegovy-acces-precoce/ 2024-07-09T09:07:19+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/progestatifs-meningiomes/ 2024-05-03T06:18:58+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-beyfortus/ 2024-07-09T09:07:00+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/amp-cancer/ 2024-05-24T06:38:24+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/perforation_januskinase_adalimumab/ 2024-06-20T12:18:53+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/rappel-vaccins-covid19-omicron/ 2024-06-20T12:18:35+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/risque-violence-enfants/ 2024-06-20T12:18:17+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/acetate-nomegestrol-meningiome/ 2024-06-20T12:17:46+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/snds-revue/ 2024-05-28T06:16:43+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-trastuzumab-emtansine/ 2024-06-20T12:17:12+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/age-relatif-methylphenidate-orthophonie/ 2025-06-13T07:16:36+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid19-vaccins-myocardites-jama/ 2024-11-06T14:43:20+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/covid%e2%80%9119-vaccins-suivi-myocardites/ 2024-08-26T19:07:29+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccins-covid%e2%80%91saignements-menstruels-vaccine/ 2024-11-06T14:42:31+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/intervalle-doses-covid-19-myocardites-natcomm/ 2024-11-06T14:42:14+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/trastuzumab-deruxtecan/ 2024-11-21T11:02:13+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/chlormadinone-meningiome/ 2024-11-21T11:02:29+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccination-coqueluche-femmes-enceintes/ 2024-12-10T07:34:57+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/biosimilaires-adalimumab-psoriasis/ 2024-12-10T07:34:23+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/prep-vih-2024/ 2024-12-19T12:53:29+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/determinants-vaccination-covid19-enfants/ 2024-12-19T12:52:39+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/trastuzumab-deruxtecan-cancer-sein/ 2025-01-08T09:38:29+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/contraception-orale-progestative-meningiome-intracranien/ 2025-06-13T07:21:40+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/impact-mesures-acetate-cyproterone/ 2025-01-29T14:12:18+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/biosimilaires-mici-enfants/ 2025-02-11T08:03:57+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-medicaments-personnes-agees/ 2025-02-24T08:36:43+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-semaglutide-wegovy-adultes/ 2025-03-03T09:17:59+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-fluoroquinolones/ 2025-07-11T15:40:15+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/efficacite-nirsevimab/ 2025-04-07T12:54:00+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/malformations-thiopurines-antitnf-mici/ 2025-04-07T12:53:32+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/medroxyprogesterone-meningiome/ 2025-05-05T13:43:59+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccination-covid19-femmes-enceintes/ 2025-05-05T13:43:36+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/prep-soins-primaires/ 2025-05-05T13:43:15+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/nirsevimab-caracteristiques-sociodemographiques/ 2025-05-05T13:42:28+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-abrysvo-femmes-enceintes/ 2025-09-25T08:03:59+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/macrolides-grossesse-malformations/ 2025-06-10T11:49:54+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/ipp-enfants-moins-de-1an/ 2025-06-10T11:49:36+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/age-relatif-orthophonie-jamanetworkopen2025/ 2025-06-19T11:44:39+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/impact-mesures-nomegestrol-chlormadinone-meningiomes/ 2025-07-24T06:24:05+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/desogestrel-levonorgestrel-meningiomes/ 2025-07-24T06:23:15+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vasectomie-2010-2022/ 2025-07-24T06:23:35+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-antiepileptiques-2013-2021/ 2025-09-25T07:50:41+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/utilisation-fluoroquinolones-2/ 2025-09-25T07:50:09+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/efficacite-securite-trastuzumab-deruxtecan/ 2025-10-16T08:07:58+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/inegalites-vaccination-vrs/ 2025-10-16T08:07:24+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/inihibteurs-pdl1-cancer-bronchique/ 2025-11-27T11:07:55+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccination-covid19-grossesse-malformations/ 2025-11-27T11:08:11+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/contraceptifs-france-2012-2022/ 2025-11-27T11:08:28+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/valproate-peres-tnd/ 2025-11-27T11:08:47+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/securite-abrysvo-grossesse-obstetrics-gynecology/ 2025-12-15T13:33:49+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/securite-abrysvo-grossesse/ 2025-11-27T11:09:20+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/suivi-prep-vih-2025/ 2025-12-15T13:33:07+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/diu-grossesse-extra-uterine/ 2025-12-15T13:29:44+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccination-covid19-mortalite/ 2026-02-09T13:10:56+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccination-arnm-covid19-mortalite-jamanetworkopen/ 2025-12-15T13:48:44+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/mesusage-fluoroquinolones/ 2026-02-09T13:10:14+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/efficacite-beyfortus-abrysvo-vrs/ 2026-02-09T13:09:47+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/beyfortus-abrysvo-jama/ 2025-12-22T16:14:31+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/pompes-insuline-externes/ 2026-03-09T09:33:35+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/medroxyprogesterone-injectable/ 2026-03-09T09:33:52+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/sacituzumab-govitecan-cancer-sein/ 2026-03-09T09:34:06+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/vaccination-hpv/ 2026-03-09T09:34:19+00:00 weekly 1.0 https://www.epi-phare.fr/rapports-detudes-et-publications/dostarlimab-cancer-endometre/ 2026-03-27T09:26:02+00:00 weekly 1.0